Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Epidermal Growth Factor Receptor
100%
Epithelioid Sarcoma
100%
Rapamycin
18%
Sarcoma Cells
18%
Erlotinib
18%
Cell Proliferation
12%
Cell Invasion
12%
Tissue Microarray
12%
Receptor Blockade
12%
Clinical Trials
6%
Signaling Pathway
6%
Deregulation
6%
Receptor Activation
6%
Growth Effect
6%
Western Blot
6%
Growth Inhibition
6%
Immunohistochemistry
6%
Quantitative Reverse Transcriptase PCR
6%
Cell Survival
6%
Cyclin D1 (CCND1)
6%
Epidermal Growth Factor Receptor Signaling
6%
Severe Combined Immunodeficient Mice
6%
Survival Effect
6%
New Therapies
6%
Matrix metalloproteinase-9 (MMP-9)
6%
Matrix metalloproteinase-2 (MMP-2)
6%
Dual Inhibition
6%
MTOR Inhibitor
6%
Cell Motility
6%
Tumor Inhibition
6%
In Vivo Growth
6%
Cytostatic
6%
Xenograft Model
6%
Small Molecule Inhibitors
6%
MTOR Pathway
6%
Pathway Activation
6%
Anti-EGFR
6%
Cell Culture Assay
6%
Proliferation Effect
6%
Migration Effect
6%
PTEN Expression
6%
Survival Migration
6%
Invasion Effect
6%
Medicine and Dentistry
Mammalian Target of Rapamycin
100%
Epidermal Growth Factor Receptor
100%
Epithelioid Sarcoma
100%
Rapamycin
18%
Erlotinib
18%
Cell Proliferation
12%
Cell Invasion
12%
Tissue Microarray
12%
Receptor Blocking
12%
Sarcoma Cell Line
12%
In Vitro
6%
Xenograft
6%
Clinical Trial
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Cell Survival
6%
Cyclin D1
6%
Immunohistochemistry
6%
Growth Inhibition
6%
Signal Transduction
6%
SCID Mouse
6%
Gelatinase B
6%
Cell Line
6%
Gelatinase A
6%
Cell Motility
6%
mTOR Signaling
6%
Western Blot
6%
Anti-Epidermal Growth Factor Receptor
6%
Cancer Inhibition
6%
Sarcoma Cell
6%
Cytostatic Agent
6%
Cell Culture Assays
6%
Immunology and Microbiology
Epidermal Growth Factor
100%
Sirolimus
25%
Cell Proliferation
16%
Growth Inhibition
16%
Cell Invasion
16%
Receptor Blocking
16%
Sarcoma Cell Line
16%
Western Blot
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Signal Transduction
8%
Cell Line
8%
Cell Culture
8%
Xenograft
8%
Cell Survival
8%
Cyclin D1
8%
SCID Mouse
8%
Cell Motility
8%
mTOR Signaling
8%
Sarcoma Cell
8%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Epithelioid Sarcoma
100%
Rapamycin
18%
Erlotinib
18%
Clinical Trial
6%
Western Blot
6%
Cell Culture
6%
Gelatinase B
6%
Cancer Inhibition
6%
Gelatinase A
6%
RNA Directed DNA Polymerase
6%
Cytostatic Agent
6%
SCID Mouse
6%
Cyclin D1
6%